Abstract
The lymphokine interleukin-2 (IL-2; also termed T-cell growth factor) causes the proliferation of activated T-cell clones1,2. Effector T-cell lines exhibiting suppressor, helper and cytotoxic activities have been established by growth of appropriately stimulated cells in IL-2-containing medium3,4. In addition, IL-2 has been shown to provide requisite T-cell ‘help’ in a number of in vitro immune response assays, including the generation of cytotoxic T cells from thymocyte (and nude spleen cell) cultures5 and the induction of erythrocyte-specific antibody in T cell-deficient populations6. We report here a further activity of IL-2, one previously attributed solely to interferon—the ability to augment the cytotoxic activity of natural killer (NK) cells. This conclusion was reached from the observation that preparations of IL-2, which lacked interferon, caused a rapid increase in NK cell activity. This ability to augment cytotoxity was removed from IL-2 preparations, not only by absorption with IL-2 receptor bearing cells, but also by precipitation with a monoclonal antibody directed against IL-2.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Gillis, S. & Smith, K. A. Nature 268, 154 (1977).
Nabholz, M., Engers, H., Collavo, D. & North, M. Curr. Topics Microbiol. Immun. 81, 176 (1978).
Gillis, S., Baker, P. E., Ruscetti, F. W. & Smith, K. A. J. exp. Med. 148, 1093 (1978).
Watson, J. J. exp. Med. 150, 1510 (1979).
Gillis, S., Smith, K. A. & Watson, J. D. J. Immun. 124, 1954 (1980).
Watson, J., Aarden, L. & Lefkovitz, I. J. Immun. 122, 209 (1979).
Herberman, R. B., Nunn, M. E. & Lavrin, D. H. Int. J. Cancer 16, 216 (1975).
Gillis, S., Ferm, M. M., Ou, W. & Smith, K. A. J. Immun. 120, 2027 (1978).
Tracey, D. E., Wolfe, S. A., Durdik, J. M. & Henney, C. S. J. Immun. 119, 1145 (1977).
Gidlund, M., Orn, A., Wigzell, H., Senik, A. & Gresser, I. Nature 273, 759 (1978).
Djeu, J. Y., Heinbaugh, J. A., Holden, H. T. & Herberman, R. B. J. Immun. 122, 175 (1979).
Kirchner, H., Zawatszky, R. & Schirrmacher, V. Eur. J. Immun. 9, 97 (1979).
Watson, J., Mochizuki, D. M., Frank, M. B. & Gillis, S. in Pharmacology of the Reticulo-endothelial System (ed. Webb, D.) (Dekker, New York, in the press).
Watson, J., Gillis, S., Marbrook, J., Mochizuki, D. & Smith, K. A. J. exp. Med. 150, 849 (1979).
Hirsch, M. S., Proffitt, M. R. & Black, P. H. Contemporary Topics Immunobiol. 6, 209 (1977).
Smith, K. A., Gillis, S., Ruscetti, F., Baker, P. E. & McKenzie, D. Proc. N.Y. Acad. Sci. 332, 423 (1979).
Baker, P., Gillis, S. & Smith, K. A. J. exp. Med. 149, 273 (1979).
Gillis, S. & Henney, C. S. J. Immun. (in the press).
Kohler, G. & Milstein, C. Nature 256, 495 (1975).
Durdik, J. M., Beck, B. N., Clark, E. A. & Henney, C. S. J. Immun. 125, 683 (1980).
Young, W. W., Hakomori, S., Durdik, J. M. & Henney, C. S. J. Immun. 124, 199 (1980).
Ledbetter, J. & Nowinski, R. C. J. Virol. 23, 315 (1977).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Henney, C., Kuribayashi, K., Kern, D. et al. Interleukin-2 augments natural killer cell activity. Nature 291, 335–338 (1981). https://doi.org/10.1038/291335a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/291335a0
This article is cited by
-
Exploring pathway interactions to detect molecular mechanisms of disease: 22q11.2 deletion syndrome
Orphanet Journal of Rare Diseases (2023)
-
Primary CD33-targeting CAR-NK cells for the treatment of acute myeloid leukemia
Blood Cancer Journal (2022)
-
Role of IL-24 in NK cell activation and its clinical implication in systemic lupus erythematosus
Clinical Rheumatology (2021)
-
Functional and metabolic targeting of natural killer cells to solid tumors
Cellular Oncology (2020)
-
IL-27 enhances IL-15/IL-18-mediated activation of human natural killer cells
Journal for ImmunoTherapy of Cancer (2019)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.